A Novel Diagnosis Method Based on Methylation Analysis of SHOX2 and Serum Biomarker for Early Stage Lung Cancer.
Wenhai HuangHao HuangShuishen ZhangXueping WangJuan OuyangZhichao LinPei-Song ChenPublished in: Cancer control : journal of the Moffitt Cancer Center (2021)
Our results indicated that the DT model calculated from the TM and CYFRA21 -1 can accurately classify LC and benign diseases, which showed better diagnostic performance than traditional serum parameter.